{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:41:48Z","timestamp":1782337308627,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008968","name":"Istanbul Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015732","name":"Bahcesehir University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jmgm.2024.108762","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T21:45:40Z","timestamp":1712267140000},"page":"108762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Covalent docking-driven virtual screening of extensive small-molecule libraries against Bruton tyrosine kinase for the identification of highly selective and potent novel therapeutic candidates"],"prefix":"10.1016","volume":"130","author":[{"given":"Ezgi","family":"Sambur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalehan","family":"Oktay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0426-0905","authenticated-orcid":false,"given":"Serdar","family":"Durda\u011f\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jmgm.2024.108762_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jmgm.2024.108762_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/bbrc.1999.1407","article-title":"Pleckstrin homology domains of tec family protein kinases","volume":"265","author":"Okoh","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.jmgm.2024.108762_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/wsbm.86","article-title":"Hematopoietic stem cell: self-renewal versus differentiation","volume":"2","author":"Seita","year":"2010","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"issue":"7","key":"10.1016\/j.jmgm.2024.108762_bib4","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.4049\/jimmunol.1200490","article-title":"Colonel Bruton's kinase defined the molecular basis of X-linked agammaglobulinemia, the first primary immunodeficiency","volume":"188","author":"Khan","year":"2012","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jmgm.2024.108762_bib5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/ijms24020930","article-title":"Top selling (2026) small molecule orphan drugs: a journey into their chemistry","volume":"24","author":"Benedetto Tiz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"49","key":"10.1016\/j.jmgm.2024.108762_bib6","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1038\/sj.onc.1203958","article-title":"Signaling network of the Btk family kinases","volume":"19","author":"Qiu","year":"2000","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jmgm.2024.108762_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.immuni.2015.11.011","article-title":"The neutrophil btk signalosome regulates integrin activation during sterile inflammation","volume":"44","author":"Volmering","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jmgm.2024.108762_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of Bruton's tyrosine kinase in B cells and malignancies","volume":"17","author":"Pal Singh","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jmgm.2024.108762_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687458","article-title":"Targeting bruton's tyrosine kinase in CLL","volume":"12","author":"Ahn","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jmgm.2024.108762_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2015-03-585075","article-title":"Targeted therapies in CLL: mechanisms of resistance and strategies for management","volume":"126","author":"Woyach","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jmgm.2024.108762_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc3702","article-title":"Targeting Bruton's tyrosine kinase in B cell malignancies","volume":"14","author":"Hendriks","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"6180","key":"10.1016\/j.jmgm.2024.108762_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/334353a0","article-title":"An inositol tetrakisphosphate-containing phospholipid in activated neutrophils","volume":"334","author":"Traynor-Kaplan","year":"1988","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jmgm.2024.108762_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10409238.2016.1215288","article-title":"The PI3K pathway in B cell metabolism","volume":"51","author":"Jellusova","year":"2016","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.jmgm.2024.108762_bib14","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1110\/ps.9.12.2377","article-title":"Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia","volume":"9","author":"Tzeng","year":"2000","journal-title":"Protein Sci."},{"issue":"3","key":"10.1016\/j.jmgm.2024.108762_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pro.321","article-title":"Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases","volume":"19","author":"Marcotte","year":"2010","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2024.108762_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cellsig.2017.08.002","article-title":"The role of G protein-coupled receptors in lymphoid malignancies","volume":"39","author":"Nugent","year":"2017","journal-title":"Cell. Signal."},{"issue":"17","key":"10.1016\/j.jmgm.2024.108762_bib17","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2013.53.1046","article-title":"Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies","volume":"32","author":"Ponader","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.jmgm.2024.108762_bib18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3324\/haematol.2014.119123","article-title":"The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia","volume":"100","author":"Wiestner","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jmgm.2024.108762_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrc.2017.121","article-title":"Targeting B cell receptor signalling in cancer: preclinical and clinical advances","volume":"18","author":"Burger","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"18","key":"10.1016\/j.jmgm.2024.108762_bib20","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1182\/blood-2017-01-761726","article-title":"Acquired mutations associated with ibrutinib resistance in Waldenstr\u00f6m macroglobulinemia","volume":"129","author":"Xu","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jmgm.2024.108762_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins"},{"issue":"7","key":"10.1016\/j.jmgm.2024.108762_bib22","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1021\/ct200133y","article-title":"Improved treatment of ligands and Coupling effects in empirical calculation and rationalization of pKa values","volume":"7","author":"S\u00f8ndergaard","year":"2011","journal-title":"J. Chem. Theor. Comput."},{"issue":"3","key":"10.1016\/j.jmgm.2024.108762_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"6\u20137","key":"10.1016\/j.jmgm.2024.108762_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2024.108762_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.760283","article-title":"Improving small-molecule force field parameters in ligand binding studies","volume":"8","author":"Raniolo","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"7","key":"10.1016\/j.jmgm.2024.108762_bib26","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/ci500118s","article-title":"Docking covalent inhibitors: a parameter free approach to pose prediction and scoring","volume":"54","author":"Zhu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2024.108762_bib27","series-title":"Proceedings of the ACM\/IEEE Conference on Supercomputing (SC06)","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"10.1016\/j.jmgm.2024.108762_bib28","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1063\/1.449071","article-title":"The Nose\u2013Hoover thermostat","volume":"83","author":"Evans","year":"1985","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.jmgm.2024.108762_bib29","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1021\/acs.jctc.5b00748","article-title":"A comparison of barostats for the mechanical characterization of metal-organic frameworks","volume":"11","author":"Rogge","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"issue":"2","key":"10.1016\/j.jmgm.2024.108762_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"5","key":"10.1016\/j.jmgm.2024.108762_bib31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.jmgm.2024.108762_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.jmgm.2024.108762_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3906\/biy-2106-61","article-title":"Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease","volume":"45","author":"Oktay","year":"2021","journal-title":"Turk. J. Biol."},{"issue":"10\u201311","key":"10.1016\/j.jmgm.2024.108762_bib34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/00498250600861660","article-title":"Algorithms for network analysis in systems-ADME\/Tox using the MetaCore and MetaDrug platforms","volume":"36","author":"Ekins","year":"2006","journal-title":"Xenobiotica"},{"issue":"29","key":"10.1016\/j.jmgm.2024.108762_bib35","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jmgm.2024.108762_bib36","doi-asserted-by":"crossref","first-page":"E47","DOI":"10.1188\/15.CJON.E47-E51","article-title":"Ibrutinib: a new targeted therapy for hematologic cancers","volume":"19","author":"Smithson","year":"2015","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"25","key":"10.1016\/j.jmgm.2024.108762_bib37","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia","volume":"373","author":"Burger","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.jmgm.2024.108762_bib38","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.3390\/molecules26237411","article-title":"The development of BTK inhibitors: a five-year update","volume":"26","author":"Tasso","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.jmgm.2024.108762_bib39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/BF00124321","article-title":"Hydration in drug design. 1. Multiple hydrogen-bonding features of water molecules in mediating protein-ligand interactions","volume":"9","author":"Poornima","year":"1995","journal-title":"J. Comput. Aided Mol. Des."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326324000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326324000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T21:25:32Z","timestamp":1716845132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326324000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":39,"alternative-id":["S1093326324000627"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2024.108762","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Covalent docking-driven virtual screening of extensive small-molecule libraries against Bruton tyrosine kinase for the identification of highly selective and potent novel therapeutic candidates","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2024.108762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108762"}}